je.st
news
Tag: cell
New robotic bending cell adds capabilities to Quebec manufacturer
2016-06-24 20:59:30| Canadian Plastics Headlines
Matritechs goal is to remain on the cutting edge of technology through continued investment. Its most recent acquisition is a robotic bending cell. The post New robotic bending cell adds capabilities to Quebec manufacturer appeared first on Canadian Plastics.
Tags: cell
manufacturer
capabilities
adds
Stanford solar tandem cell shows promise for efficient solar-driven water-splitting to produce hydrogen
2016-06-23 20:56:36| Green Car Congress
Tags: shows
cell
produce
efficient
California OTS observational study finds driver cell phone use up despite dangers
2016-06-22 23:56:02| Green Car Congress
Tags: phone
study
california
cell
Last Three: Can Stem Cell Save Northern White Rhinos From Extinction?
2016-06-17 08:33:00| Climate Ark Climate Change & Global Warming Newsfeed
Nature World News: In a quest to halt mammalian extinction, scientists are using stem cells and assisted reproduction technology. But with only three northern white rhinos (Ceratotherium simum cottoni) left, can science save them from completely vanishing? Sudan, Najin and Fatu--who are kept at Ol Pejeta Conservancy in Kenya--cannot breed naturally because they are related. It is with this situation that scientists came up with an audacious plan to save them from the brink of extinction. According to EcoWatch.com,...
Tags: save
white
cell
northern
Mercks KEYTRUDA (pembrolizumab) Demonstrates Superior Progression-Free and Overall Survival Compared to Chemotherapy as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer
2016-06-16 12:45:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KEYNOTE-024 Studied Patients Whose Tumors Expressed High Levels of PD-L1 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the KEYNOTE-024 trial investigating the use of KEYTRUDA (pembrolizumab), in patients with previously untreated advanced non-small cell lung cancer (NSCLC) whose tumors expressed high levels of PD-L1 (tumor proportion score of 50 percent or more), met its primary endpoint. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Courtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
cell
treatment
compared
Sites : [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] next »